跳至主要内容
临床试验/NCT00437580
NCT00437580Unknown4 期

Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus (VRE) Intestinal Carriage : a Double Blind Randomized Pilot Study

University Hospital, Clermont-Ferrand2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2007年2月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
24
试验地点
2
主要终点
Reduction of the duration of Vancomycin Resistant Enterococcus intestinal carriage.

研究概览

简要总结

This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks regimen with placebo.A stool culture will be performed every week for 5 weeks (during the administration of treatment) then every two weeks until 3 consecutive negative stool culture for VRE.

详细描述

This study aims to reduce the duration of VRE intestinal carriage by the administration of Lactobacillus casei rhamnosus (strain Lcr 35 LC). Patients will be blindly randomized to be assigned to a 5 weeks regimen with the probiotic (10 9 lactobacillus bid) or to a 5 weeks regimen with placebo.A stool culture will be performed every week for 5 weeks (during the administration of treatment) then every two weeks until 3 consecutive negative stool culture for VRE.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18;
  • Vancomycin Resistant Enterococcus intestinal carriage

排除标准

  • Neutropenia <1000 /mm3,
  • Immunosuppressive drugs,
  • Inhalation

结局指标

主要结局

Reduction of the duration of Vancomycin Resistant Enterococcus intestinal carriage.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other

研究点 (2)

Loading locations...

相似试验